BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $266,000 | -19.9% | 1,825 | -34.8% | 0.03% | -13.2% |
| Q1 2022 | $332,000 | -15.5% | 2,800 | -1.8% | 0.04% | -11.6% |
| Q4 2021 | $393,000 | +5.6% | 2,850 | +6.5% | 0.04% | -4.4% |
| Q3 2021 | $372,000 | +61.0% | 2,675 | +12.6% | 0.04% | +60.7% |
| Q2 2021 | $231,000 | +1.8% | 2,375 | -10.4% | 0.03% | -12.5% |
| Q4 2020 | $227,000 | +104.5% | 2,650 | +22.4% | 0.03% | +68.4% |
| Q1 2019 | $111,000 | +38.8% | 2,165 | +0.7% | 0.02% | +18.8% |
| Q4 2018 | $80,000 | -1.2% | 2,150 | 0.0% | 0.02% | +14.3% |
| Q3 2018 | $81,000 | -12.9% | 2,150 | -8.5% | 0.01% | -17.6% |
| Q2 2018 | $93,000 | +78.8% | 2,350 | +17.5% | 0.02% | +70.0% |
| Q1 2018 | $52,000 | -17.5% | 2,000 | -14.9% | 0.01% | -16.7% |
| Q4 2017 | $63,000 | – | 2,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |